EI
VIR icon

Ellevest Inc’s Vir Biotechnology VIR Stock Holding History

Ellevest Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22
Closed -$1K – 1873
2022
Q2 		$1K Buy
+22
New +$514 ﹤0.01% 1332
2022
Q1 		– Sell
-5
Closed – – 1641
2021
Q4 		$0 Buy
+5
New +$196 ﹤0.01% 1666
2021
Q3 		– Sell
-2
Closed – – 1588
2021
Q2 		$0 Buy
+2
New +$91 ﹤0.01% 1428

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellevest Inc's VIR Position: Q3 2022 in Review

Ellevest Inc sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 22 shares — an estimated $1K sold.

Ellevest Inc first reported a position in VIR in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 221 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

  • Ellevest Inc reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 22 Vir Biotechnology shares in Q3 2022, an estimated $1K.
  • Ellevest Inc first reported a position in Vir Biotechnology in Q2 2021 and held it in 3 quarters.
  • Ellevest Inc's Vir Biotechnology position peaked at $1K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.